Oncología Hepática
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (3)
2023
-
An International Expert Delphi Consensus on Defining Textbook Outcome in Liver Surgery (TOLS)
Annals of Surgery, Vol. 277, Núm. 5, pp. 821-828
2022
-
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
Clinical Cancer Research, Vol. 28, Núm. 16, pp. 3537-3545
2005
-
Leptin therapy does not affect inflammatory markers [2] (multiple letters)
Journal of Clinical Endocrinology and Metabolism